Loading data for MDWD — first visit, this takes a few seconds.
MediWound Ltd. (MDWD)
NasdaqGM: MDWD
· 实时价格 · USD
13.11
-0.60 (-4.38%)
收盘价： Sep 11, 2026, 3:59 PM
13.11
+0.00%
盘后: 7:30 PM
股价、关键数字和最新消息，都在这一页。
MediWound Ltd.（MDWD）股价、分析与数据
-4.38% (1D)
| 买价 | 10.22 |
| 市值 | 169M |
| 营收（TTM） | 11.9M |
| 净利润（TTM） | -20.2M |
| 0.14 | |
| -2.16 | |
| n/a | |
| -5.72 | |
| 市净率（TTM） | 4.75 |
| 市销率（TTM） | 14.27 |
| 财报日期 | Nov 19, 2026 |
| 卖价 | 18.25 |
| 成交量 | 78,332 |
| 20日均量 | 88,269 |
| 开盘价 | 13.81 |
| 前收盘价 | 13.71 |
| 日内区间 | 12.95 - 13.81 |
| 52周区间 | 12.52 - 20.03 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 MDWD
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops Esc...
公司完整简介财报意外
MediWound 已于 Aug 13, 2026 发布季度财报：
- 营收为 $3.09M 低于预期 $0, ， -45.83% 同比下滑.
- 每股收益为 -0.57 超出预期 0.20, ， 53.66% 同比增长.
第 1 页，共 2 页